Semiparametric and Empirical Process Methods in Oncology
肿瘤学中的半参数和经验过程方法
基本信息
- 批准号:6608179
- 负责人:
- 金额:$ 16.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-07-01 至 2005-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The long-term goal of the proposed project is to develop flexible semi parametric analysis tools for cancer research in both epidemiologic studies and clinical trials. The change in title from the previous award reflects the completion of most of the aims in the original grant (R29 CA75 142) as well as a greater emphasis on semi parametric and empirical process methods which played an increasingly important role throughout the previous grant's multivariate clinical trial research. Semi parametric models are useful in medical research because they involve both a parametric component which is usually easy to interpret and a nonparametric component which permits greater flexibility in the presence of biologic uncertainty. The three proposed interrelated aims are: (1) Develop and evaluate inferential methods for semi parametric proportional hazards frailty regression models to account for unobserved individual-level heterogeneity in time-to-event data; (2) Develop and evaluate tools for flexible semi parametric risk-factor testing in cancer studies; and (3) Create tools for computationally efficient inference for survival, quantile and hazard functions in semi parametric models. The primary statistical research methods used for these challenging and interrelated aims include empirical process and semi parametric inference techniques as well as Monte Carlo computational approaches. These aims will provide cancer researchers with a significantly improved collection of useful modeling tools.
描述(由申请人提供):拟议项目的长期目标是为流行病学研究和临床试验中的癌症研究开发灵活的半参数分析工具。与前一个奖项相比,标题的改变反映了原始奖项(R29 CA75 142)中大部分目标的完成,以及对半参数和经验过程方法的更多重视,这些方法在前一个奖项的多元临床试验研究中发挥了越来越重要的作用。半参数模型在医学研究中很有用,因为它们既包括通常易于解释的参数分量,也包括允许在存在生物不确定性时具有更大灵活性的非参数分量。提出的三个相互关联的目标是:(1)开发和评估半参数比例风险脆弱回归模型的推断方法,以解释时间到事件数据中未观察到的个体水平的异质性;(2)开发和评估癌症研究中灵活的半参数风险因素测试工具;以及(3)创建半参数模型中生存、分位数和风险函数的计算高效推断的工具。用于这些具有挑战性和相互关联的目标的主要统计研究方法包括经验过程和半参数推理技术以及蒙特卡罗计算方法。这些目标将为癌症研究人员提供显著改进的有用建模工具集合。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL R KOSOROK其他文献
MICHAEL R KOSOROK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL R KOSOROK', 18)}}的其他基金
Core C - Integrated Quantitative Science (IQS)
核心 C - 综合定量科学 (IQS)
- 批准号:
10334087 - 财政年份:2022
- 资助金额:
$ 16.9万 - 项目类别:
Core C - Integrated Quantitative Science (IQS)
核心 C - 综合定量科学 (IQS)
- 批准号:
10705601 - 财政年份:2022
- 资助金额:
$ 16.9万 - 项目类别:
Applying novel statistical approaches to develop a decision framework for hybrid randomized controlled trial designs which combine internal control arms with patients' data from real-world data source
应用新颖的统计方法来开发混合随机对照试验设计的决策框架,该设计将内部对照组与来自真实世界数据源的患者数据相结合
- 批准号:
10449112 - 财政年份:2020
- 资助金额:
$ 16.9万 - 项目类别:
Applying novel statistical approaches to develop a decision framework for hybrid randomized controlled trial designs which combine internal control arms with patients' data from real-world data source
应用新颖的统计方法来开发混合随机对照试验设计的决策框架,该设计将内部对照组与来自真实世界数据源的患者数据相结合
- 批准号:
10250391 - 财政年份:2020
- 资助金额:
$ 16.9万 - 项目类别:
Applying novel statistical approaches to develop a decision framework for hybrid randomized controlled trial designs which combine internal control arms with patients' data from real-world data source
应用新颖的统计方法来开发混合随机对照试验设计的决策框架,该设计将内部对照组与来自真实世界数据源的患者数据相结合
- 批准号:
10186428 - 财政年份:2020
- 资助金额:
$ 16.9万 - 项目类别:
MULTIVARIATE GROUP SEQUENTIAL CANCER CLINICAL TRIALS
多变量组序贯癌症临床试验
- 批准号:
6173406 - 财政年份:1997
- 资助金额:
$ 16.9万 - 项目类别:
MULTIVARIATE GROUP SEQUENTIAL CANCER CLINICAL TRIALS
多变量组序贯癌症临床试验
- 批准号:
2896097 - 财政年份:1997
- 资助金额:
$ 16.9万 - 项目类别:
Semiparametric and Empirical Process Methods in Oncology
肿瘤学中的半参数和经验过程方法
- 批准号:
7100396 - 财政年份:1997
- 资助金额:
$ 16.9万 - 项目类别:
相似海外基金
From lymphatics to evaluating resolution therapeutics in clinical trials
从淋巴管到评估临床试验中的解决疗法
- 批准号:
MR/Y013050/1 - 财政年份:2024
- 资助金额:
$ 16.9万 - 项目类别:
Fellowship
RareKids-CAN: Pediatric Rare Disease Clinical Trials and Treatment Network
RareKids-CAN:儿科罕见病临床试验和治疗网络
- 批准号:
495575 - 财政年份:2023
- 资助金额:
$ 16.9万 - 项目类别:
Operating Grants
Unbiased estimation in hierarchical models for Clinical trials
临床试验分层模型中的无偏估计
- 批准号:
2884930 - 财政年份:2023
- 资助金额:
$ 16.9万 - 项目类别:
Studentship
ISimcha Technology Platform for Recruiting a Diverse Population of Older Adults into Clinical Trials
ISimcha 技术平台,用于招募不同的老年人群进行临床试验
- 批准号:
10761602 - 财政年份:2023
- 资助金额:
$ 16.9万 - 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 16.9万 - 项目类别:
CCTN-CONTRACEPTIVE DEVELOPMENT PROGRAM-NICHD CONTRACEPTIVE CLINICAL TRIALS NETWORK-FEMALE SITES-CORE FUNCTION ACTIVITIES
CCTN-避孕发展计划-NICHD避孕临床试验网络-女性站点-核心功能活动
- 批准号:
10895949 - 财政年份:2023
- 资助金额:
$ 16.9万 - 项目类别:
CONTRACEPTIVE CLINICAL TRIALS NETWORK, CCTN - FEMALE SITES 'CORE FUNCTION ACTIVITIES
避孕临床试验网络,CCTN - 女性站点的核心功能活动
- 批准号:
10891325 - 财政年份:2023
- 资助金额:
$ 16.9万 - 项目类别:
Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Zimbabwe (ZIM-CASCADE)
在津巴布韦实施艾滋病毒/宫颈癌预防 CASCADE 临床试验 (ZIM-CASCADE)
- 批准号:
10758129 - 财政年份:2023
- 资助金额:
$ 16.9万 - 项目类别: